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AN
ATYPICAL
CASE
OF
MYCOPHENOLATE INDUCED COLITIS:

LATE-ONSET

Muhammad Shabbir Rawala1, Anand Kumar1, Thang Nguyen1,
Venkata Kishore Mukku1, Asif Hussain1, Kathleen Gamilla-Crudo1,
Muhammad Mujtaba1. 1University of Texas Medical Branch
Chronic immunosuppression may increase the risk of posttransplant infection and medication-related injury. Mycophenolic
acid (MPA) is a well-known immunosuppressive agent for postorgan transplants and various autoimmune disorders. We present
a case of a young woman who developed late-onset
mycophenolate-induced
colitis
after
initiation
of
an
immunosuppressive agent.
We present a 28-year-old kidney transplant patient with
hypertension who was placed on MPA after renal transplantation.
The patient had been doing well but started having abdominal
pain, bloating, diarrhea approximately 15 months after initiation
of therapy. The symptoms were associated with a weight loss of 20
pounds. The patient had a complete gastrointestinal (GI) workup,
including cultures and viral serologies, and treatment was initiated
for suspected small bowel bacterial overgrowth. She did not
respond to prophylactic antibiotics and proton pump inhibitors.
The patient underwent a colonoscopy along with a biopsy (Figure
I) that identified mycophenolate-induced colitis. MPA was
discontinued and the patient was switched to Azathioprine leading
to improvement of the symptoms.
Mycophenolate causes immunosuppression by inhibiting ratelimiting enzymes for purines synthesis in lymphocytes. MPA can
cause cytotoxic and cytostatic effects on GI epithelium by a similar
mechanism of disrupting pathways in purine synthesis. The
common symptoms on the GI tract caused by MPA are nausea,
vomiting, ulcers, gastritis, diarrhea, abdominal pain, and rarely
colitis.
Gastrointestinal symptoms are reported with mycophenolate;
however, the onset of colitis after being on the medication for
almost 15 months is infrequent. This case suggests that
mycophenolate toxicity should be considered in evaluating lateonset posttransplant diarrhea regardless of the duration of
therapy.
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SURVEILLANCE-BASED RISK
STENOTIC
HEMODIALYSIS
ACCESSES:

SCORE PREDICTS
ARTERIOVENOUS

Lalathaksha Kumbar1, Brad Astor2, Jerry Yee1. 1Henry Ford Health
System; 2University of Wisconsin School of Medicine and Public
Health

S54

This prospective study evaluated a novel risk score based on
Vasc-Alert surveillance to identify hemodialysis vascular access
with significant stenosis.
Patients receiving hemodialysis using arteriovenous access with
Vasc-Alert scores ≥8 (high score) or ≤ 3 (low score) were
prospectively enrolled. Each patient was screened for clinical
symptoms of access dysfunction, received a physical examination
and a point of care ultrasound scan of the access arm. Subjects
were referred to angiogram by the primary care team as per
clinical necessity. Clinical monitoring (CM) includes clinical
symptoms and signs. Luminal narrowing > 50% found by
ultrasound or angiogram is considered significant.
A total of 38 patients [20 in the high score (HS) group and 18 in
the low score (LS) group] were enrolled. There is no significant
difference in age, gender, diabetes, and hypertension between the
groups (all p>0.10), while the LS group had a higher prevalence of
coronary artery disease (55% vs. 25%, p=0.05). CM is positive in
60% of HS vs. 39% in LS (p=0.19). HS group is more likely to have
significant stenosis than those in the LS group (65% vs. 17%
p=0.003). Only 58% of subjects with positive CM have significant
stenosis (11 of 19). A total of 19 patients had no positive CM
findings. HS alone identified 4 out of these 19 patients with
significant stenosis (p=0.05). Adjusted for risk score, a positive
CM finding, and prior stenotic history were not significantly
associated with significant stenosis. Every unit increase in the
score was associated with 34% higher odds of stenosis (adjusted
odds ratio [aOR] = 1.34; 95% confidence interval [95% CI]: 1.051.70; P=0.02). The HS group is associated with 7-fold higher
stenosis odds than the LS group after adjustment (aOR=7.38; 95%
CI: 1.44-37.82; p=0.02). The sensitivity and specificity of the HS
group in identifying stenosis are 81% and 68%, respectively. The
positive predictive value of HS is 0.65%, and the negative
predictive value is 0.83.
The Vasc-Alert score predicts stenotic hemodialysis vascular
access with high reliability. The score provides an objective
measure for risk stratification even in those without positive CM
findings.
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RENAL
REPLACEMENT
LIPOMATOSIS:
UNEXPECTED FINDING ON KIDNEY IMAGING:

AN

Naga Goparaju1, Dakota Robertson1, Greg Hiett1, Pavan
Annamaraju1. 1Johnston Memorial Hospital
Renal Replacement Lipomatosis (RRL) is a rare disorder
characterized by the destruction of renal parenchyma by an
inflammatory or non-inflammatory process followed by the
deposition of lipomatous tissue. We report a case of RRL in a
patient with chronic obstructive uropathy.
An 81 yo male with nephrolithiasis and BPH presented to the
ER with worsening fatigue. His metabolic panel showed a BUN of
150 mg/dL and serum creatinine of 9.6 mg/dL. Renal ultrasound
revealed normal size kidneys, bilateral moderate cortical atrophy
with bilateral hydronephrosis, and a right staghorn calculus. CT
abdomen-pelvis confirmed bilateral ureteral obstruction at the
level of the ureterovesical junction from the thickened bladder
wall. The right kidney showed lipomatous infiltration of the renal
sinus and encasement of the renal pelvis and proximal right ureter
with fatty tissue. Thin septations within the fat encasing the renal
pelvis and proximal ureter, effacement of the renal collecting
system, marked dilatation, and tortuosity of the right ureter was
noted ( Fig 1 ). These findings clinched the diagnosis of RRL
involving the right kidney. The patient declined any intervention
and opted for hospice care.
RRL is mainly seen with calculus disease (75% of cases). Aging,
post-transplantation,
chronic
pyelonephritis,
and
renal
tuberculosis are other associated conditions. It seldom involves
both kidneys. The presenting symptoms are nonspecific, such as
flank pain or abdominal mass. Xanthogranulomatous
pyelonephritis (XGP) can mimic RRL due to its association with
stones and chronic inflammation. Histology can help differentiate
XGP from RRL. A CT scan is the diagnostic test of choice for RRL.
MRI can further confirm the diagnosis
RRL is an uncommon finding on renal imaging. It is often
associated with stone disease. CT scan is helpful to characterize
and distinguish it from other renal neoplasms.
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